Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1989-12-19
1991-07-30
Schain, Howard E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514179, 530330, A61K 3700, A61K 906
Patent
active
050360507
ABSTRACT:
A composition for use in the topical treatment of skin disorders such as dermatitis or poison ivy, which comprises an effective amount of thymopentin and a suitable carrier is provided. A method for treating skin disorders and a method for making a topical composition are disclosed.
REFERENCES:
patent: 4190646 (1980-02-01), Goldstein et al.
patent: 4261886 (1981-04-01), Goldstein et al.
patent: 4361673 (1982-11-01), McGregor
patent: 4420424 (1983-12-01), Geiger et al.
patent: 4428938 (1984-01-01), Kisfaludy et al.
patent: 4505853 (1985-03-01), Goldstein et al.
patent: 4547489 (1985-10-01), Goldstein et al.
patent: 4614517 (1986-09-01), Ruoslahti et al.
patent: 4629723 (1986-12-01), Goldstein et al.
patent: 4742048 (1988-05-01), Bouchaudon et al.
patent: 4749690 (1988-06-01), Goldstein
patent: 4753958 (1988-06-01), Weinstein
Liden, Surv. Immunol. Res., 4: Suppl. 1, pp. 24-29 (1985).
F. Pipino et al., Arzneim.-Forsch/Drug Res., 38:116-119 (1988).
G. Goldstein, Nature (London), 247:11-14 (1974).
R. S Basch et al., Proc. Natl. Acad. Sci. USA., 71:1474-1478 (1974).
M. P. Scheid et al., J. Exp. Med., 147:1727-1743 (1978), [Scheid I].
M. P. Scheid et al., Science, 190:1211-1213 (1975), [Scheid II].
G. E. Ranges et al., J. Exp. Med., 156:1057-1064 (1982).
K. Venkatasubramania et al., Proc. Nat. Acad. Sci. USA., 83:3171-3174 (1986).
M. G. Malaise et al., in "Immunoregulatory UCLA Symposium on Molecular and Cellular Biology", eds. G. Goldstein et al. (Liss, New York) (1986), [Malaise I].
G. H. Sunshine et al., J. Immunol., 120:1594-1599 (1978).
Kisfaludy et al., Hoppe-Seyler's Z. Physiol. Chem., B. D. 364, S. 933-940 (1983), [Kisfaludy I].
G. A. Heavner et al., Peptides, 7:1015 (1986).
T. Abiko et al., Chem. Pharm. Bull., 27(9):2233-2237 (1979), [Abiko I].
T, Abiko et al., Chem. Pharm. Bull., 28(8):2057-2511 (1980), [Abiko II].
T. Abiko et al., CHem. Pharm. Bull., 29(8):2322-2329 (1981), [Abiko III].
T. Abiko, Chem. Pharm. Bull., 29(11):3320-3325 (1981), [Abiko IV].
T. Abiko et al., J. A-pl. Biochem., 7:408-422 (1985), [Abiko V].
K. Kisfaludy et al., Ann. Immunol. Hung., 25:189-193 (1985). [Kisfaludy II].
E. Rentz, Arch. Geschwulstforsch, 54:113-118 (1984).
G. I. Chipens et al., Bioorganicheskaya Khimiya, 11(4):437-446, (1985).
Kessler et al., Liebigs. Ann. Chem., (1986), pp. 869-931 and German Application No. DE3401545 (1985).
E. Ivan et al., Arch. Toxical., Suppl. 8, pp. 495-498 (1985).
Chu et al., Journal of Investigative Dermatology, 81:194-197 (1983).
Audhya et al., Int. J. Peptide Protein Res., 22:568-572 (1983).
Malaise et al., The Lancet, 832-836 (1985).
Audhya et al., Biochem., 20:6195-6200 (1980).
Sundal et al., Immune Regulation by Characterized Peptides, 121-136 (Liss, New York) (1987).
A. Castells et al., Surv. Immunol. Res., 4:63-69, Suppl. 1 (1985).
J. DeMaubeuge et al., Surv. Immunol. Res., 4:30-36, Suppl. 1 (1985).
N. Friedmann, Surv. Immunol. Res., 4:139-154, Suppl. 1 (1985).
N. Clumeck et al., Int. J. Clin. Pharm. Res., IV(6):459-463 (1984).
W. Barcellini et al., Clin. Exp. Immunol., 67:537-543 (1987).
Audhya Tapan
Goldstein Gideon
Venkatasubramanian Krishnamurthy
Immunobiology Research Institute, Inc.
Koh Choon
Schain Howard E.
LandOfFree
Compositions containing thymopentin for topical treatment of ski does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions containing thymopentin for topical treatment of ski, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions containing thymopentin for topical treatment of ski will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1542670